Piper Sandler lowered the firm’s price target on GE HealthCare (GEHC) to $88 from $104 and keeps an Overweight rating on the shares ahead of quarterly results. The firm notes that policy and broad economic uncertainty has seemingly created opportunities for investors to do value shopping. Piper does see the pressure on GE HealthCare over the past month as overdone, but the risk level here is higher than most large caps and it’s not obvious to the firm that Q1 results/guidance update will be a clearing event.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE Hlthcare Tech Inc put volume heavy and directionally bearish
- GE HealthCare price target lowered to $95 from $110 at Mizuho
- GE HealthCare price target lowered to $95 from $103 at BTIG
- Hold Rating for GE Healthcare Technologies Inc. Amid US-China Trade Tensions and Global Recession Concerns
- China starts anti-dumping probe of imported medical CT tubes, Global Times says